Why some people are likely to get better results …C0NTINUE READING HERE >>>
Share on PinterestScientists have found different weight loss results in people taking tirzepatide. NurPhoto/Getty ImagesTirzepatide, a once-weekly GIP/GLP-1 receptor agonist, is a medicine used for weight reduction in adults with obesity.A new analysis of the SURMOUNT clinical trials reveals that the medicine, administered as a once-weekly injection, leads to significant weight reduction.Across all doses and trials, women lost up to 24.6% of their body weight compared to 18.1% in men,…
>
Leave a Reply